Menopause: It’s so Hot Right Now
Menopause is a $600 billion market opportunity that remains largely untapped.
Menopause is a $600 billion market opportunity that remains largely untapped.
One major obstacle to precision medicine for all? The cost of sequencing each person’s genome. New sequencing startups could change that.
Handheld ultrasound devices could eventually become as common as stethoscopes, and might even be used by patients themselves to send images to doctors from home.
The United States spends $696 billion on Medicare – so reforming the existing plan distribution model couldn’t be more vital. The process should be as straightforward and stress-free as possible, and that way is through...
We are in a critical decade of action that will support the energy transition to drive decarbonization. More than 100 heads of state and over 35,000 participants came together in Sharm El-Sheikh, Egypt, for two...
While working to understand not only his own rare disease but also how the broader healthcare industry develops treatments for rare diseases as a whole, Onno Faber uncovered the building blocks of his new company.
Infectious disease and public policy experts investigated the global pandemic response, cataloged its many failures and assembled recommendations for future. But sadly their words will probably fall flat.
New “Industry Cloud” solutions reduce cost and accelerate innovation. The end result will be better outcomes for patients, businesses, and society.
In two new studies, scientists report on symptoms, frequency, and other implications of long Covid